CapLaw-2026-39

  • SOPHiA GENETICS‘s Public Offering of USD 57.5 Million of Ordinary Shares

    On 19 June 2026, SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, closed its underwritten public offering with total gross proceeds of USD 57.5 million. TD Cowen acted as the lead book-running manager for the offering. Guggenheim Securities acted as book-running manager, and BTIG and Craig-Hallum acted as lead managers for the offering.

    By

    CapLaw

    Reference:
    Read more: SOPHiA GENETICS‘s Public Offering of USD 57.5 Million of Ordinary Shares